Findings from a head-to-head trial comparing Victoza® (liraglutide) and lixisenatide, both in combination with metformin, demonstrated a significantly greater reduction in HbA1c of -1.83% for liraglutide vs -1.21% for lixisenatide in adults with type 2 diabetes (Novo Nordisk)
Diabetes News
Tag: Victoza
New study with Victoza® (liraglutide) showed improvements in blood glucose control in adults with type 2 diabetes who fasted during Ramadan
New findings showed that adults with type 2 diabetes treated with Victoza®, in combination with metformin, experienced similar improvements in blood glucose control while fasting during Ramadan (four weeks) compared with sulfonylurea (SU) plus metformin (Novo Nordisk)